| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 Apr 2024 | 24 Apr 2024 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the Listing Regulations notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday April 30 2024 inter-alia to consider approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31 2024 and to consider recommendation of a final dividend if any on the equity shares of the Company for the financial year ended March 31 2024 subject to declaration and approval of the same by the shareholders at the ensuing Annual General Meeting Approval of Dividend of Rs. 2 per equity share by the Board of Directors of the Company. Outcome of Board meeting Approval of Scheme of Amalgamation of Buli Chemicals India Private Limited - WOS with Neogen Chemicals Limited- Holding company (As Per BSE Announcement Dated on 30.04.2024) | ||
| Board Meeting | 9 Feb 2024 | 1 Feb 2024 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended from time to time notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Friday February 9 2024 inter-alia to consider approve and take on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2023 Unaudited results for the quarter and nine months ended December 31, 2023 (As Per BSE Announcement Dated on 10.02.2024) we wish to inform you that the Board of Directors of the Company had at its meeting held today i.e., Friday, February 9, 2024, at 3:00 p.m. and concluded at 9:25 p.m., inter alia considered and approved the following: 1) Unaudited financials for the Quarter and nine months ended 31-12-2023 2)Statement of Deviation/ Variation in utilization of funds (Statement) as at December 31,2023 3) Incorporation of Wholly Owned Subsidiary (WOS) in Japan 4) issuance of Corporate Guarantee on behalf of Buli Chemicals India Private Limited, Wholly Owned Subsidiary (WOS) upto Rs. 50 crores and Others. (As Per BSE Announcement Dated on: 09/02/2024) | ||
| Board Meeting | 8 Nov 2023 | 1 Nov 2023 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Pursuant to regulation 29 and 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended from time to time notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday November 8 2023 inter-alia to consider approve and take on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2023. The Board of Directors of the Company had at its meeting held today i.e., Wednesday, November 8, 2023, inter alia considered and approved the following: 1. Un-audited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2023 2. Subscription of upto 40,00,000 equity shares at a price of Rs. 10 each on rights issue basis of its Wholly Owned Subsidiary i.e., Neogen Ionics Limited. 3.3. Investing by way of Loan up to Rs. 250 Crores in its Wholly Owned Subsidiary (WOS) i.e., Neogen Ionics Limited Approval of Financial Results for the Quarter and Half year ended September 30, 2023 by the Board of Directors in its meeting held on November 8 , 2023 (As per BSE Announcement Dated on 08/11/2023) | ||
| Board Meeting | 5 Oct 2023 | 30 Sep 2023 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/10/2023 inter alia to consider and approve Pursuant to regulation 29 of the Listing Regulations we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday October 5 2023 inter alia to consider evaluate and approve the proposal for raising of funds by way of issue of equity shares in one or more tranche by way of a Preferential Issue. for a consideration and at such price as may be arrived at pursuant to Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations 2018 (each as amended from time to time) (ICDR Regulations) read with the applicable provisions of the Companies Act 2013. With regards to the captioned subject and pursuant to Regulation 30(2) read with Para A of Part A of Schedule III the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 (Listing Regulations), we wish to inform you that the Board of Directors at their meeting held today i.e. Thursday, October 5, 2023 which commenced at 7:45 P.M. and concluded at 9.45 p.m. inter alia, considered and approved: 1. Issuance of up to 14,42,358 Equity Shares of face value of Rs. 10 each (Equity Shares) at a price of Rs. 1754.07 per Equity Share including a premium of Rs. 1744.07 per Equity Share, aggregating up to Rs. 2,52,99,96,897 (Rupees Two Hundred and Fifty Two Crore Ninety Nine Lakh Ninety Six Thousand Eight Hundred Ninety Seven only) (As per BSE Announcement Dated on 05/10/2023) | ||
| Board Meeting | 5 Aug 2023 | 29 Jul 2023 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30 2023. The Board may in its meeting to be held on August 5, 2023 consider, evaluate and approve the alteration of Authorised Capital and consequent alteration of Memorandum of Association of the COmpany in accordance with the Applicable laws and subject to necessary approvals as may be required. (As Per BSE Announcement Dated on 02.08.2023) Board of Directors of the Company had at its meeting held today i.e. Saturday, August 5, 2023, considered and approved the items as mentioned in the attached outcome Board of Directors in its meeting held on August 5, 2023 approved the matters mentioned in the attachment (As Per BSE Announcement Dated on 05.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
